Concepts (142)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mobility Limitation | 8 | 2020 | 208 | 0.900 |
Why?
|
| Algorithms | 4 | 2018 | 536 | 0.700 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2019 | 2 | 0.610 |
Why?
|
| Disability Evaluation | 3 | 2019 | 241 | 0.610 |
Why?
|
| Transposition of Great Vessels | 1 | 2019 | 2 | 0.610 |
Why?
|
| Heart Failure, Systolic | 1 | 2019 | 15 | 0.610 |
Why?
|
| Geriatric Assessment | 5 | 2019 | 335 | 0.590 |
Why?
|
| Aortic Diseases | 1 | 2019 | 62 | 0.580 |
Why?
|
| Data Interpretation, Statistical | 2 | 2018 | 116 | 0.580 |
Why?
|
| Patient Care Team | 1 | 2019 | 123 | 0.570 |
Why?
|
| Psychometrics | 4 | 2019 | 137 | 0.560 |
Why?
|
| Exercise | 5 | 2020 | 605 | 0.480 |
Why?
|
| Cognition | 1 | 2018 | 547 | 0.430 |
Why?
|
| Video Recording | 2 | 2013 | 61 | 0.400 |
Why?
|
| Epistasis, Genetic | 3 | 2012 | 43 | 0.380 |
Why?
|
| Prostatic Neoplasms | 3 | 2012 | 489 | 0.370 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2012 | 821 | 0.360 |
Why?
|
| Models, Theoretical | 2 | 2014 | 139 | 0.360 |
Why?
|
| Aorta | 1 | 2012 | 125 | 0.360 |
Why?
|
| Aging | 4 | 2020 | 942 | 0.350 |
Why?
|
| Health Knowledge, Attitudes, Practice | 5 | 2019 | 316 | 0.330 |
Why?
|
| Health Status | 1 | 2013 | 356 | 0.330 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2019 | 1437 | 0.330 |
Why?
|
| Walking | 3 | 2020 | 199 | 0.320 |
Why?
|
| Humans | 26 | 2020 | 32262 | 0.300 |
Why?
|
| Aged, 80 and over | 11 | 2019 | 3893 | 0.300 |
Why?
|
| Aged | 15 | 2020 | 10249 | 0.290 |
Why?
|
| Male | 22 | 2020 | 19429 | 0.290 |
Why?
|
| Quality of Life | 2 | 2016 | 968 | 0.280 |
Why?
|
| Cardiovascular Diseases | 4 | 2017 | 1159 | 0.270 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 904 | 0.270 |
Why?
|
| Computational Biology | 1 | 2008 | 99 | 0.260 |
Why?
|
| Female | 18 | 2020 | 19935 | 0.230 |
Why?
|
| Risk Factors | 8 | 2019 | 3933 | 0.230 |
Why?
|
| Hypoglycemic Agents | 2 | 2015 | 186 | 0.210 |
Why?
|
| Computer Simulation | 2 | 2018 | 251 | 0.190 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2012 | 1050 | 0.190 |
Why?
|
| Age Factors | 5 | 2019 | 1178 | 0.180 |
Why?
|
| Time Factors | 4 | 2019 | 2203 | 0.170 |
Why?
|
| Diabetes Mellitus | 2 | 2014 | 390 | 0.170 |
Why?
|
| Pulmonary Valve Insufficiency | 1 | 2020 | 4 | 0.170 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2020 | 86 | 0.160 |
Why?
|
| Reproducibility of Results | 4 | 2019 | 756 | 0.150 |
Why?
|
| Psychology | 1 | 2019 | 25 | 0.150 |
Why?
|
| Nursing Staff, Hospital | 1 | 2019 | 14 | 0.150 |
Why?
|
| Aorta, Thoracic | 1 | 2019 | 81 | 0.150 |
Why?
|
| European Continental Ancestry Group | 2 | 2013 | 1076 | 0.140 |
Why?
|
| Physical Fitness | 1 | 2019 | 120 | 0.140 |
Why?
|
| Cause of Death | 1 | 2019 | 236 | 0.140 |
Why?
|
| Health Education | 2 | 2016 | 149 | 0.140 |
Why?
|
| Patient Readmission | 1 | 2019 | 135 | 0.140 |
Why?
|
| Retrospective Studies | 2 | 2019 | 3609 | 0.140 |
Why?
|
| Recovery of Function | 1 | 2019 | 238 | 0.140 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 551 | 0.140 |
Why?
|
| Actigraphy | 1 | 2017 | 15 | 0.130 |
Why?
|
| Disease Progression | 1 | 2019 | 591 | 0.130 |
Why?
|
| Risk Reduction Behavior | 1 | 2017 | 117 | 0.130 |
Why?
|
| Insulin | 2 | 2015 | 359 | 0.130 |
Why?
|
| Substance-Related Disorders | 1 | 2018 | 140 | 0.120 |
Why?
|
| Life Style | 2 | 2020 | 394 | 0.120 |
Why?
|
| Middle Aged | 7 | 2019 | 11837 | 0.120 |
Why?
|
| Linear Models | 2 | 2019 | 426 | 0.120 |
Why?
|
| Research Design | 1 | 2018 | 316 | 0.120 |
Why?
|
| Reference Values | 2 | 2015 | 238 | 0.120 |
Why?
|
| Lower Extremity | 1 | 2016 | 99 | 0.110 |
Why?
|
| Exercise Therapy | 1 | 2017 | 249 | 0.110 |
Why?
|
| Predictive Value of Tests | 2 | 2017 | 880 | 0.110 |
Why?
|
| Statistics as Topic | 1 | 2014 | 99 | 0.110 |
Why?
|
| Single-Blind Method | 3 | 2020 | 192 | 0.100 |
Why?
|
| Risk Assessment | 1 | 2019 | 1423 | 0.100 |
Why?
|
| Indians, North American | 1 | 2013 | 75 | 0.100 |
Why?
|
| Health Literacy | 1 | 2013 | 27 | 0.100 |
Why?
|
| Prognosis | 4 | 2020 | 1529 | 0.100 |
Why?
|
| Task Performance and Analysis | 1 | 2013 | 50 | 0.090 |
Why?
|
| Case-Control Studies | 2 | 2012 | 854 | 0.090 |
Why?
|
| Aortic Coarctation | 1 | 2012 | 4 | 0.090 |
Why?
|
| Self Efficacy | 1 | 2013 | 74 | 0.090 |
Why?
|
| Iohexol | 1 | 2012 | 8 | 0.090 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2012 | 19 | 0.090 |
Why?
|
| Cardiac-Gated Imaging Techniques | 1 | 2012 | 18 | 0.090 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2012 | 38 | 0.090 |
Why?
|
| Quality Control | 1 | 2012 | 43 | 0.090 |
Why?
|
| Motor Activity | 1 | 2014 | 332 | 0.090 |
Why?
|
| Treatment Outcome | 1 | 2019 | 3408 | 0.090 |
Why?
|
| Contrast Media | 1 | 2012 | 136 | 0.090 |
Why?
|
| Child | 2 | 2018 | 2430 | 0.080 |
Why?
|
| Infant, Newborn | 1 | 2012 | 666 | 0.080 |
Why?
|
| Hip Fractures | 1 | 2010 | 26 | 0.080 |
Why?
|
| Infant | 1 | 2012 | 1010 | 0.070 |
Why?
|
| Adolescent | 2 | 2018 | 3509 | 0.070 |
Why?
|
| Child, Preschool | 1 | 2012 | 1233 | 0.070 |
Why?
|
| Logistic Models | 1 | 2010 | 743 | 0.070 |
Why?
|
| Multifactorial Inheritance | 1 | 2008 | 24 | 0.070 |
Why?
|
| Obesity | 1 | 2014 | 1111 | 0.060 |
Why?
|
| African Americans | 1 | 2013 | 1335 | 0.060 |
Why?
|
| Decision Support Techniques | 1 | 2008 | 129 | 0.060 |
Why?
|
| Taiwan | 2 | 2020 | 11 | 0.060 |
Why?
|
| Hypoglycemia | 2 | 2015 | 43 | 0.060 |
Why?
|
| Sex Factors | 2 | 2019 | 656 | 0.050 |
Why?
|
| Heart Ventricles | 1 | 2020 | 146 | 0.040 |
Why?
|
| Confidence Intervals | 1 | 2019 | 141 | 0.040 |
Why?
|
| Acceleration | 1 | 2019 | 64 | 0.040 |
Why?
|
| Marijuana Abuse | 1 | 2018 | 18 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2019 | 309 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2020 | 415 | 0.030 |
Why?
|
| Tobacco Use Disorder | 1 | 2018 | 90 | 0.030 |
Why?
|
| Stroke Volume | 1 | 2020 | 417 | 0.030 |
Why?
|
| Alcoholism | 1 | 2018 | 97 | 0.030 |
Why?
|
| Physical Therapy Modalities | 1 | 2017 | 81 | 0.030 |
Why?
|
| Vulnerable Populations | 1 | 2016 | 37 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 759 | 0.030 |
Why?
|
| Resistance Training | 1 | 2016 | 58 | 0.030 |
Why?
|
| Patient Education as Topic | 1 | 2017 | 245 | 0.030 |
Why?
|
| Adult | 2 | 2020 | 9252 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2015 | 164 | 0.030 |
Why?
|
| Patient Compliance | 1 | 2016 | 206 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 292 | 0.030 |
Why?
|
| Culture | 1 | 2014 | 34 | 0.030 |
Why?
|
| African Continental Ancestry Group | 1 | 2015 | 338 | 0.030 |
Why?
|
| Incidence | 1 | 2017 | 1241 | 0.030 |
Why?
|
| Young Adult | 1 | 2020 | 2643 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 716 | 0.030 |
Why?
|
| Attitude to Health | 1 | 2014 | 137 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 772 | 0.020 |
Why?
|
| Medicine | 1 | 2013 | 36 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2015 | 484 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2016 | 863 | 0.020 |
Why?
|
| Minority Groups | 1 | 2013 | 81 | 0.020 |
Why?
|
| Arthritis | 1 | 2013 | 30 | 0.020 |
Why?
|
| Reaction Time | 1 | 2013 | 123 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2016 | 864 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2013 | 178 | 0.020 |
Why?
|
| Weight Loss | 1 | 2014 | 410 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2012 | 248 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2014 | 1839 | 0.020 |
Why?
|
| North Carolina | 1 | 2013 | 1300 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2012 | 543 | 0.020 |
Why?
|
| United States | 1 | 2017 | 4068 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2010 | 197 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2008 | 124 | 0.020 |
Why?
|
| Genotype | 1 | 2008 | 702 | 0.020 |
Why?
|
| Hypertension | 1 | 2013 | 980 | 0.010 |
Why?
|